Objective: To determine whether perioperative transfusion of leukocyte-depleted blood is a predictor of recurrence and survival in patients with head and neck cancer.
Design: Retrospective case series.
Setting: Tertiary referral teaching center.
Patients: Patients undergoing head and neck surgery for malignant disease between October 1996 and October 2002.
Seikaly H, Chau J, Harris JR. P220 Transfusion as a Predictor of Recurrence and Survival in Head and Neck Cancer Surgery. Arch Otolaryngol Head Neck Surg. 2006;132(8):908–909. doi:10.1001/archotol.132.8.908-c
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.